IBEX CEO to Present at Sachs Associates 5th Annual North American Forum, Presentation to Be Available Via Webcast

IBEX Technologies Inc. (TSX:IBT), an innovator in the development of diagnostics and therapeutics for the management of cancer and arthritis, today announced that Paul Baehr, President, Chief Executive Officer and Chairman, will present at the Sachs Associates 5th Annual North American Forum for Investing & Partnering in Biotech & Medtech.

Mr. Baehr’s presentation will take place on March 13, 2006 at 12:10 P.M. at The Fairmont Copley Plaza Hotel in Boston, MA. Mr. Baehr will be available for one-on-one meetings during the forum. His presentation will be available live via webcast and for replay at www.investorcalendar.com/CEPage.asp?ID=102435

About IBEX

IBEX is focused on the development of diagnostics and therapeutics for the management of cancer and arthritis. The Company’s cancer program is based on a novel family of genes known as kallikreins. IBEX is developing kallikrein-based diagnostics for the screening and monitoring of cancer. Additionally, IBEX is exploring the role of kallikreins in metastatic disease for use as potential therapeutics. The Company’s arthritis program is based on a series of biomarkers of cartilage degradation and synthesis.

IBEX markets a number of products, including its proprietary enzymes (heparinases and chondroitinases), as well as a series of arthritis and kallikrein-based assays. IBEX(TM) Heparinase I is used in many leading blood monitoring devices, while IBEX’s arthritis assays are used by leading pharmaceutical companies for research purposes. The Company is located in Montreal, Quebec, Canada. For more information about IBEX, please visit www.ibex.ca.

About Sachs Associates

Sachs Associates is a leading international forum for those interested in investing and partnering in the biotech and medtech industries. Going into its fifth year, the meeting attracts over 500 of the brightest players in the industry and provides prime executive-level networking and deal-making opportunities. The event features executive round-tables, presentations by mid-caps, small-caps, IPO prospects and venture-backed biotech and medtech companies.

For more information about Sachs Associates, visit www.sachsforum.com

IBEX TECHNOLOGIES INC. (TSX:IBT)